{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:50:26Z","timestamp":1771879826448,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12020-021-02779-x","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T05:06:17Z","timestamp":1622869577000},"page":"592-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-1745","authenticated-orcid":false,"given":"Juan P.","family":"Brito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-3320","authenticated-orcid":false,"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Sangaralingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yandong","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9906-7106","authenticated-orcid":false,"given":"Xiaoxi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Smallridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Bernet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-3447","authenticated-orcid":false,"given":"Nilay D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasia J.","family":"Lipska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,5]]},"reference":[{"key":"2779_CR1","doi-asserted-by":"publisher","unstructured":"R. Rodriguez-Gutierrez, S. Maraka, N.S. Ospina, V.M. Montori, J.P. Brito, Levothyroxine overuse: time for an about face? Lancet Diab. Endocrinol. (2017). https:\/\/doi.org\/10.1016\/S2213-8587(16)30276-5","DOI":"10.1016\/S2213-8587(16)30276-5"},{"key":"2779_CR2","doi-asserted-by":"publisher","unstructured":"E.D. Kantor, C.D. Rehm, J.S. Haas, A.T. Chan, E.L. Giovannucci, Trends in prescription drug use among adults in the United States from 1999-2012. Jama (2015). https:\/\/doi.org\/10.1001\/jama.2015.13766","DOI":"10.1001\/jama.2015.13766"},{"key":"2779_CR3","doi-asserted-by":"publisher","unstructured":"M. Viswanathan, C.E. Golin, C.D. Jones et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann. Intern. Med. (2012). https:\/\/doi.org\/10.7326\/0003-4819-157-11-201212040-00538","DOI":"10.7326\/0003-4819-157-11-201212040-00538"},{"key":"2779_CR4","doi-asserted-by":"publisher","unstructured":"J.S. Ross, S. Rohde, L. Sangaralingham et al. Generic and brand-name thyroid hormone drug use among commercially insured and medicare beneficiaries, 2007 Through 2016. J. Clin. Endocrinol. Metab. (2019). https:\/\/doi.org\/10.1210\/jc.2018-02197","DOI":"10.1210\/jc.2018-02197"},{"key":"2779_CR5","doi-asserted-by":"publisher","unstructured":"N. Huo, L. Chen, A.U. Mishuk et al. Generic levothyroxine initiation and substitution among Medicare and Medicaid populations: a new user cohort study. Endocrine (2020). https:\/\/doi.org\/10.1007\/s12020-020-02211-w","DOI":"10.1007\/s12020-020-02211-w"},{"key":"2779_CR6","unstructured":"American Thyroid Association, The Endocrine Society, and American Association of Clinical Endocrinologists. Joint Statement on the U.S. Food and Drug Administration\u2019s Decision Regarding Bioequivalence of Levothyroxine Sodium (2021). https:\/\/www.endocrine.org\/advocacy\/position-statements\/bioequivalence-of-sodium-levothyroxine"},{"key":"2779_CR7","unstructured":"Endocrine Society. Bioequivalence of Sodium Levothyroxine (2008). https:\/\/www.optum.com\/content\/dam\/optum\/resources\/productSheets\/5302_Data_Assets_Chart_Sheet_ISPOR.pdf"},{"key":"2779_CR8","doi-asserted-by":"publisher","unstructured":"A. Grossman, I. Feldhamer, J. Meyerovitch, Treatment with levothyroxin in subclinical hypothyroidism is associated with increased mortality in the elderly. Eur. J. Intern. Med. (2018). https:\/\/doi.org\/10.1016\/j.ejim.2017.11.010","DOI":"10.1016\/j.ejim.2017.11.010"},{"key":"2779_CR9","doi-asserted-by":"publisher","unstructured":"P.N. Taylor, A. Iqbal, C. Minassian et al. Falling threshold for treatment of borderline elevated thyrotropin levels\u2014balancing benefits and risks: evidence from a large community-based study. JAMA Intern. Med. (2014). https:\/\/doi.org\/10.1001\/jamainternmed.2013.11312","DOI":"10.1001\/jamainternmed.2013.11312"},{"key":"2779_CR10","doi-asserted-by":"crossref","unstructured":"R.C. Smallridge, L.R. Sangaralingham, R. Mwangi, F. Kusumoto, H. Van Houten, V. Bernet, Comparison of Incident Cardiovascular Event Rates Between Generic and Brand l-Thyroxine for the Treatment of Hypothyroidism. Mayo Clinic Proceedings (2019)","DOI":"10.1016\/j.mayocp.2018.11.030"},{"key":"2779_CR11","doi-asserted-by":"publisher","unstructured":"P.J. Wallace, N.D. Shah, T. Dennen, P.A. Bleicher, W.H. Crown, Optum Labs: building a novel node in the learning health care system. Health Affairs (2014). https:\/\/doi.org\/10.1377\/hlthaff.2014.0038","DOI":"10.1377\/hlthaff.2014.0038"},{"key":"2779_CR12","unstructured":"OptumLabs. Real world health care experiences from over 150 million unique individuals since 1993 (2015). https:\/\/www.optum.com\/content\/dam\/optum\/resources\/productSheets\/5302_Data_Assets_Chart_Sheet_ISPOR.pdf"},{"key":"2779_CR13","doi-asserted-by":"publisher","unstructured":"J. Jonklaas, A. Bianco, A. Bauer et al., American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014). https:\/\/doi.org\/10.1089\/thy.2014.0028","DOI":"10.1089\/thy.2014.0028"},{"key":"2779_CR14","doi-asserted-by":"publisher","unstructured":"J.R. Desai, C.L. Hyde, S. Kabadi et al. Utilization of positive and negative controls to examine comorbid associations in observational database studies. Med. Care (2017). https:\/\/doi.org\/10.1097\/MLR.0000000000000640","DOI":"10.1097\/MLR.0000000000000640"},{"key":"2779_CR15","doi-asserted-by":"publisher","unstructured":"R.A. Deyo, D.C. Cherkin, M.A. Ciol, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. (1992). https:\/\/doi.org\/10.1016\/0895-4356(92)90133-8","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"2779_CR16","doi-asserted-by":"publisher","unstructured":"D.F. McCaffrey, B.A. Griffin, D. Almirall, M.E. Slaughter, R. Ramchand, L.F. Burgette, A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat. Med. (2013). https:\/\/doi.org\/10.1002\/sim.5753","DOI":"10.1002\/sim.5753"},{"key":"2779_CR17","doi-asserted-by":"publisher","unstructured":"J.M. Carswell, J.H. Gordon, E. Popovsky, A. Hale, R.S. Brown, Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism. J. Clin. Endocrinol. Metab. (2013). https:\/\/doi.org\/10.1210\/jc.2012-3125","DOI":"10.1210\/jc.2012-3125"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02779-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T13:12:11Z","timestamp":1636117931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02779-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,5]]},"assertion":[{"value":"18 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"J.S.R. has received research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing, from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology (NEST), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R01HS025164), and from the Laura and John Arnold Foundation to establish the Good Pharma Scorecard at Bioethics International and to establish the Collaboration for Research Integrity and Transparency (CRIT) at Yale. N.D.S. has received research support through Mayo Clinic from the Centers of Medicare and Medicaid Innovation, from the Agency for Healthcare Research and Quality (R01HS025164; R01HS025402; R03HS025517; U19HS024075), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R56HL130496; R01HL131535), National Science Foundation, and from the Patient Centered Outcomes Research Institute (PCORI). K.J.L. receives support from the Centers of Medicare and Medicaid Services (CMS) and the National Institute on Aging and the American Federation of Aging Research through the Paul Beeson Career Development Award (K23AG048359). R.C.S. receives support from the Alfred D. and Audrey M. Petersen Professorship in Cancer Research. D.J.G., Y.Q., Z.W., and L.Z. are employed by the US Food and Drug Administration. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}